molecular tumor board
A multidisciplinary team that reviews complex genomic data to guide precision cancer treatment decisions.
Full Definition
A molecular tumor board represents a specialized multidisciplinary conference where oncologists, pathologists, geneticists, and other experts review complex molecular profiling results to develop personalized treatment recommendations. These boards integrate genomic findings with clinical context, drug availability, and published evidence to optimize therapeutic strategies. The process ensures appropriate interpretation of molecular data and identification of clinical trial opportunities for patients with rare or complex genomic profiles.
Usage
Usage note: Hyphenate when used as compound modifier. Often abbreviated as MTB in subsequent references.
In Context
- "The molecular tumor board recommended off-label use of a BRAF inhibitor based on the genomic findings." — Multidisciplinary conference note
- "Patient enrollment in the basket trial was approved following molecular tumor board review." — Clinical trial documentation